NeuroScientific Biopharmaceuticals Limited Price (NSB.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

144,508,886

(0.723)%

news-img

Cash Flow Statement

NeuroScientific Biopharmaceuticals Limited

Currency: AUD

YEAR 2016 2017 2018 2019 2020 2021 2022 2023 2024
Operating Activities
Net Income -103,387.00

+0%

-261,117.00

+153%

-931,420.00

+257%

-1,658,913.00

+78%

-2,868,528.00

+73%

-3,177,831.00

+11%

-10,435,349.00

+228%

-1,068,606.00

-90%

0.00

+0%

Depreciation And Amortiz... 0.00 9.89k 42.98k 55.21k 56.66k 61.41k 64.92k 57.85k 0.00
Deferred Income Tax 0.00 0.00 -520,301.00 0.00 -582,390.00 -664,778.00 437.95k -1,861,494.00 0.00
Stock-Based Compensat... 0.00 0.00 502.15k 0.00 496.04k 625.86k 1.35M 242.75k 0.00
Change In Working Capital
Accounts Receivables 0.00 143.77k 18.15k -7,806.00 8.55k -30,263.00 -71,533.00 77.46k 0.00
Accounts Payables 131.63k -78,966.00 -21,763.00 13.87k 18.43k 114.16k 1.99M -1,580,500.00 -500,573.00
Inventory 0.00 0.00 129.78k -204,104.00 0.00 0.00 0.00 0.00 0.00
Other Working Capital 0.00 78.97k -108,013.00 190.23k 7.63k -194,887.00 158.42k -33,296.00 -2,929.00
Other Non-Cash Items -247,630.00 -45,022.00 591.73k 204.10k 582.39k 664.78k -437,947.00 1.86M 547.75k
Net Cash Provided By Op... -87,757.00

+0%

-186,419.00

+112%

-497,911.00

+167%

-1,407,410.00

+183%

-2,281,227.00

+62%

-2,601,561.00

+14%

-6,942,333.00

+167%

-2,304,340.00

-67%

44.25k

-102%

Investing Activities
Investments In Propert... -10,000.00 -15,000.00 0.00 -19,079.00 -2,382.00 -29,878.00 -3,866.00 0.00 -1,815.00
Acquisitions Net 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Purchases Of Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Sales Maturities Of Inve... 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Investing Activities -10,000.00 -15,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Cash Used For Inv... -10,000.00

+0%

-15,000.00

+50%

0.00

+0%

-19,079.00

+0%

-2,382.00

-88%

-29,878.00

+1,154%

-3,866.00

-87%

0.00

+0%

-1,815.00

+0%

Financing Activities
Debt Repayment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Common Stock Issued 0.00 322.44k 476.00k 5.93M 960.80k 13.51M 0.00 0.00 0.00
Common Stock Repurch... 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividends Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Financing Activities 40.00k 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Cash Used/Provide... 40.00k

+0%

322.44k

+706%

476.00k

+48%

5.93M

+1,146%

960.80k

-84%

13.51M

+1,306%

0.00

+0%

0.00

+0%

0.00

+0%

Effect Of Forex Changes... 62.54k 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Change In Cash 4.79k 121.02k -21,911.00 4.51M -1,322,811.00 10.88M -6,946,199.00 -2,304,339.00 42.43k
Cash At Beginning Of Per... 0.00 4.79k 125.81k 103.90k 4.61M 3.29M 14.16M 7.22M 4.91M
Cash At End Of Period 4.79k 125.81k 103.90k 4.61M 3.29M 14.16M 7.22M 4.91M 4.95M
Additional Metrics:
Operating Cash Flow -87,757.00 -186,419.00 -497,911.00 -1,407,410.00 -2,281,227.00 -2,601,561.00 -6,942,333.00 -2,304,340.00 44.25k
Capital Expenditure -10,000.00 -15,000.00 0.00 -19,079.00 -2,382.00 -29,878.00 -3,866.00 0.00 -1,815.00
Free Cash Flow -97,757.00

+0%

-201,419.00

+106%

-497,911.00

+147%

-1,426,489.00

+186%

-2,283,609.00

+60%

-2,631,439.00

+15%

-6,946,199.00

+164%

-2,304,340.00

-67%

42.43k

-102%

8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation